Savara
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Savara and other ETFs, options, and stocks.About SVRA
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis.
SVRA Key Statistics
Stock Snapshot
With a market cap of 1.14B, Savara(SVRA) trades at $5.59. The stock has a price-to-earnings ratio of -10.98.
On 2026-04-10, Savara(SVRA) stock traded between a low of $5.48 and a high of $5.91. Shares are currently priced at $5.59, which is +2.0% above the low and -5.3% below the high.
Savara(SVRA) shares are trading with a volume of 743.88K, against a daily average of 1.27M.
In the last year, Savara(SVRA) shares hit a 52-week high of $7.01 and a 52-week low of $1.89.
In the last year, Savara(SVRA) shares hit a 52-week high of $7.01 and a 52-week low of $1.89.
SVRA News
Savara Inc. recently announced that the U.K. MHRA accepted its Marketing Authorisation Application for MOLBREEVI in autoimmune PAP under Accelerated Review, whi...
Advertisement Regulatory milestones in focus for Savara stock Savara (SVRA) is back on investors’ radar after the U.K. regulator accepted the Marketing Author...
Francois Brisebois, an analyst from LifeSci Capital, reiterated the Buy rating on Savara. The associated price target remains the same with $11.00. Unlock hedg...
Analyst ratings
100%
of 8 ratingsMore SVRA News
Savara (SVRA) announced that the MHRA has accepted the submission of the Molbreevi MAA for the treatment of autoimmune PAP in the U.K. The MAA was accepted unde...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.